Hims & Hers Health (HIMS) plans a $300 million private offering of convertible senior notes due June 1, 2032, the company said Monday.
The company expects to grant initial buyers an option to purchase up to an additional $45 million of notes.
Hims & Hers plans to use the net proceeds to preserve financial flexibility while executing on its international expansion strategy, including its proposed acquisition of Eucalyptus, with closing expected in mid-2026, it said.
The company's shares were down 3.8% in premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments